The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation
Open accessAbstract
BACKGROUND: Survival after liver transplantation for early hepatocellular carcinoma (HCC) is worsened by the increasing dropout rate while waiting for a donor. AIMS: To assess the cost effectiveness of adjuvant therapy while waiting for liver transplantation in HCC patients. METHOD: Using a Markov model, a hypothetical cohort of cirrhotic patients with early HCC was considered for: (1) adjuvant treatment-resection was limited to Child-Pugh's A patients with single tumours, and percutaneous treatment was considered for Child-Pugh's A and B patients with single tumours unsuitable for resection or with up to three nodules < 3 cm; and (2) standard management. Length of waiting time ranged from six to 24 months. RESULTS: Surgical resection increased the transplantation rate (>10%) and provided gains in life expectancy of 4.8-6.1 months with an acceptable cost ($40,000/ year of life gained) for waiting lists > or = 1 year whereas it was not cost effective ($74,000/life of year gained) for shorter waiting times or high dropout rate scenarios. Percutaneous treatment increased life expectancy by 5.2-6.7 months with a marginal cost of approximately $20,000/year of life gained in all cases, remaining cost effective for all waiting times. CONCLUSIONS: Adjuvant therapies for HCC while waiting for liver transplantation provide moderate gains in life expectancy and are cost effective for waiting lists of one year or more. For shorter waiting times, only percutaneous treatment confers a relevant survival advantage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
Llovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
Self-citationLaupacis, A., Feeny, D. H., Detsky, A. S., & Tugwell, P. (1992) · Europe PMC (PubMed Central) · Cited by 1,581
Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness
Tengs, T. O., Adams, M. E., Pliskin, J. S., Safran, D. G., Siegel, J. E., Weinstein, M. C., & Graham, J. D. (1995) · Risk Analysis · doi:10.1111/j.1539-6924.1995.tb00330.x · Cited by 1,321
Small Hepatocellular Carcinoma: Treatment with Radio-frequency Ablation versus Ethanol Injection
Livraghi, T., Goldberg, S. N., Lazzaroni, S., Meloni, F., Solbiati, L., & Gazelle, G. S. (1999) · Radiology · doi:10.1148/radiology.210.3.r99fe40655 · Cited by 1,283
Llovet, J. M., Bustamante, J., Castells, A., Vilana, R., Del Carmen Ayuso, M., Sala, M., Brú, C., Rodés, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510290145 · Cited by 1,190
Self-citationThe Role of Cost-effectiveness Analysis in Health and Medicine
Russell, L. B. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540140060028 · Cited by 1,167
Recommendations for Reporting Cost-effectiveness Analyses
Siegel, J. E. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540160061034 · Cited by 1,147
Siegel, J. E. (1996) · JAMA · doi:10.1001/jama.276.16.1339 · Cited by 1,037
Livraghi, T., Giorgio, A., Marin, G., Salmi, A., de Sio, I., Bolondi, L., Pompili, M., Brunello, F., Lazzaroni, S., & Torzilli, G. (1995) · Radiology · doi:10.1148/radiology.197.1.7568806 · Cited by 939
Bruix, J., Castells, A., Bosch, J., Feu, F., Fuster, J., Garcia-Pagan, J., Visa, J., Bru, C., & Rodes, J. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70070-7 · Cited by 895
Llovet, J. M., Vilana, R., Brú, C., Bianchi, L., Salmeron, J. M., Boix, L., Ganau, S., Sala, M., Pagès, M., Ayuso, C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.24233 · Cited by 759
Self-citationLiver Transplantation for Hepatocellular Carcinoma
Bismuth, H., Majno, P., & Adam, R. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007120 · Cited by 561
Majno, P. E., Adam, R., Bismuth, H., Castaing, D., Ariche, A., Krissat, J., Perrin, H., & Azoulay, D. (1997) · Annals of Surgery · doi:10.1097/00000658-199712000-00006 · Cited by 513
Panel on cost-effectiveness in health and medicine.
Gold, M. (1996) · PubMed · Cited by 492
Llovet, J. M., Bruix, J., Fuster, J., Castells, A., Garcia-Valdecasas, J. C., Grande, L., França, A., Brú, C., Navasa, M., Ayuso, M. D., et al. (1998) · Hepatology · doi:10.1002/hep.510270616 · Cited by 382
Self-citationTobe, T., Uchino, J., Endo, Y., Oto, M., Okamoto, E., Kojiro, M., Shikata, T., Tanikawa, K., Tsuzuki, T., Mizumoto, R., et al. (1994) · Cancer · doi:10.1002/1097-0142(19941115)74:10<2772::aid-cncr2820741006>3.0.co;2-v · Cited by 335
Gains in Life Expectancy from Medical Interventions — Standardizing Data on Outcomes
Wright, J. C., & Weinstein, M. C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390606 · Cited by 334
Majno, P. E., Sarasin, F. P., Mentha, G., & Hadengue, A. (2000) · Hepatology · doi:10.1053/he.2000.5763 · Cited by 326
Vilana, R., Bruix, J., Bru, C., Ayuso, C., Solé, M., & Rodés, J. (1992) · Hepatology · doi:10.1002/hep.1840160212 · Cited by 270
Sarasin, F. P., Majno, P. E., Llovet, J. M., Bruix, J., Mentha, G., & Hadengue, A. (2001) · Hepatology · doi:10.1053/jhep.2001.23311 · Cited by 263
Self-citationEdwards, E. B., Roberts, J. P., McBride, M. A., Schulak, J. A., & Hunsicker, L. G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412703 · Cited by 237
Health-related quality of life after liver transplantation: A meta-analysis
Bravata, D. M., Olkin, I., Barnato, A. E., Keeffe, E. B., & Owens, D. K. (1999) · Liver Transplantation and Surgery · doi:10.1002/lt.500050404 · Cited by 213
Stone, M. J., Klintmalm, G. B. G., Polter, D., Husberg, B. S., Mennel, R. G., Ramsay, M. A. E., Flemens, E. E., & Goldstein, R. M. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90852-4 · Cited by 196
Stasi, M. D., Buscarini, L., Livraghi, T., Giorgoi, A., Salmi, A., Sio, I. D., Brunello, F., Solmi, L., Caturelli, E., Magnolfi, F., et al. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709002998 · Cited by 188
Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection
Ishii, H., Okada, S., Nose, H., Okusaka, T., Yoshimori, M., Takayama, T., Kosuge, T., Yamasaki, S., Sakamoto, M., & Hirohashi, S. (1996) · Cancer · Cited by 184
Llovet, J. M., Bruix, J., & Gores, G. J. (2000) · Hepatology · doi:10.1053/he.2000.6959 · Cited by 180
Self-citationSmith, T. J., Hillner, B. E., & Desch, C. E. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.18.1460 · Cited by 162
Adjuvant Chemotherapy Improves Survival After Liver Transplantation for Hepatocellular Carcinoma
Olthoff, K. M., Rosove, M. H., Shackleton, C. R., Imagawa, D. K., Farmer, D. G., Northcross, P., Pakrasi, A. L., Martin, P. B., Goldstein, L. I., Shaked, A. A., et al. (1995) · Annals of Surgery · doi:10.1097/00000658-199506000-00012 · Cited by 156
Oldhafer, K. J., Chavan, A., Frühauf, N. R., Flemming, P., Schlitt, H. J., Kubicka, S., Nashan, B., Weimann, A., Raab, R., Manns, M. P., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80123-2 · Cited by 152
The Role of Cost-Effectiveness Analysis in Health and Medicine
Russell, L. B., Gold, M. R., Siegel, J. E., Daniels, N., Weinstein, M. C., & Diaz, J. H. (1997) · Survey of Anesthesiology · doi:10.1097/00132586-199712000-00018 · Cited by 114
Hayman, J. A., Hillner, B. E., Harris, J. R., & Weeks, J. C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1022 · Cited by 97
Castellano, L., Calandra, M., Blanco, C. D. V., et al. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80324-8 · Cited by 91
Edwards, E. B., Roberts, J. P., McBride, M., Schulak, J. A., & Hunsicker, L. G. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200010000-00057 · Cited by 36
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Self-citationManagement of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Villanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Self-citation
Metadata
- Authors
- Llovet, J. M.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2002-01-01
- Volume
- 50
- Issue
- 1
- Pages
- 123-128
- ISSN
- 0017-5749 (ISSN-L)
- OpenAlex
- W2158179682
- Cited by
- 287
- References
- 35
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.